Global Lung Cancer Diagnostic Tests Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Lung Cancer Diagnostic Tests Market Size 2017-2028

2.1.2 Lung Cancer Diagnostic Tests Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Lung Cancer Diagnostic Tests Segment by Type

2.2.1 Immunoassays

2.2.2 Flow Cytometry

2.2.3 Rapid Tests

2.2.4 Molecular Assays

2.2.5 Tissue Arrays

2.2.6 Circulating Tumor Cells

2.2.7 Pharmacodiagnostics

2.2.8 Biomarkers

2.2.9 Other Diagnostics Methods

2.3 Lung Cancer Diagnostic Tests Market Size by Type

2.3.1 Lung Cancer Diagnostic Tests Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Lung Cancer Diagnostic Tests Market Size Market Share by Type (2017-2022)

2.4 Lung Cancer Diagnostic Tests Segment by Application

2.4.1 Precision Medicine

2.4.2 Personalized Medicine

2.4.3 Cancer Monitoring

2.5 Lung Cancer Diagnostic Tests Market Size by Application

2.5.1 Lung Cancer Diagnostic Tests Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Lung Cancer Diagnostic Tests Market Size Market Share by Application (2017-2022)

3 Lung Cancer Diagnostic Tests Market Size by Player

3.1 Lung Cancer Diagnostic Tests Market Size Market Share by Players

3.1.1 Global Lung Cancer Diagnostic Tests Revenue by Players (2020-2022)

3.1.2 Global Lung Cancer Diagnostic Tests Revenue Market Share by Players (2020-2022)

3.2 Global Lung Cancer Diagnostic Tests Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Lung Cancer Diagnostic Tests by Regions

4.1 Lung Cancer Diagnostic Tests Market Size by Regions (2017-2022)

4.2 Americas Lung Cancer Diagnostic Tests Market Size Growth (2017-2022)

4.3 APAC Lung Cancer Diagnostic Tests Market Size Growth (2017-2022)

4.4 Europe Lung Cancer Diagnostic Tests Market Size Growth (2017-2022)

4.5 Middle East & Africa Lung Cancer Diagnostic Tests Market Size Growth (2017-2022)

5 Americas

5.1 Americas Lung Cancer Diagnostic Tests Market Size by Country (2017-2022)

5.2 Americas Lung Cancer Diagnostic Tests Market Size by Type (2017-2022)

5.3 Americas Lung Cancer Diagnostic Tests Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Lung Cancer Diagnostic Tests Market Size by Region (2017-2022)

6.2 APAC Lung Cancer Diagnostic Tests Market Size by Type (2017-2022)

6.3 APAC Lung Cancer Diagnostic Tests Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Lung Cancer Diagnostic Tests by Country (2017-2022)

7.2 Europe Lung Cancer Diagnostic Tests Market Size by Type (2017-2022)

7.3 Europe Lung Cancer Diagnostic Tests Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Lung Cancer Diagnostic Tests by Region (2017-2022)

8.2 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Type (2017-2022)

8.3 Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Lung Cancer Diagnostic Tests Market Forecast

10.1 Global Lung Cancer Diagnostic Tests Forecast by Regions (2023-2028)

10.1.1 Global Lung Cancer Diagnostic Tests Forecast by Regions (2023-2028)

10.1.2 Americas Lung Cancer Diagnostic Tests Forecast

10.1.3 APAC Lung Cancer Diagnostic Tests Forecast

10.1.4 Europe Lung Cancer Diagnostic Tests Forecast

10.1.5 Middle East & Africa Lung Cancer Diagnostic Tests Forecast

10.2 Americas Lung Cancer Diagnostic Tests Forecast by Country (2023-2028)

10.2.1 United States Lung Cancer Diagnostic Tests Market Forecast

10.2.2 Canada Lung Cancer Diagnostic Tests Market Forecast

10.2.3 Mexico Lung Cancer Diagnostic Tests Market Forecast

10.2.4 Brazil Lung Cancer Diagnostic Tests Market Forecast

10.3 APAC Lung Cancer Diagnostic Tests Forecast by Region (2023-2028)

10.3.1 China Lung Cancer Diagnostic Tests Market Forecast

10.3.2 Japan Lung Cancer Diagnostic Tests Market Forecast

10.3.3 Korea Lung Cancer Diagnostic Tests Market Forecast

10.3.4 Southeast Asia Lung Cancer Diagnostic Tests Market Forecast

10.3.5 India Lung Cancer Diagnostic Tests Market Forecast

10.3.6 Australia Lung Cancer Diagnostic Tests Market Forecast

10.4 Europe Lung Cancer Diagnostic Tests Forecast by Country (2023-2028)

10.4.1 Germany Lung Cancer Diagnostic Tests Market Forecast

10.4.2 France Lung Cancer Diagnostic Tests Market Forecast

10.4.3 UK Lung Cancer Diagnostic Tests Market Forecast

10.4.4 Italy Lung Cancer Diagnostic Tests Market Forecast

10.4.5 Russia Lung Cancer Diagnostic Tests Market Forecast

10.5 Middle East & Africa Lung Cancer Diagnostic Tests Forecast by Region (2023-2028)

10.5.1 Egypt Lung Cancer Diagnostic Tests Market Forecast

10.5.2 South Africa Lung Cancer Diagnostic Tests Market Forecast

10.5.3 Israel Lung Cancer Diagnostic Tests Market Forecast

10.5.4 Turkey Lung Cancer Diagnostic Tests Market Forecast

10.5.5 GCC Countries Lung Cancer Diagnostic Tests Market Forecast

10.6 Global Lung Cancer Diagnostic Tests Forecast by Type (2023-2028)

10.7 Global Lung Cancer Diagnostic Tests Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Advpharma Inc

11.1.1 Advpharma Inc Company Information

11.1.2 Advpharma Inc Lung Cancer Diagnostic Tests Product Offered

11.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Advpharma Inc Main Business Overview

11.1.5 Advpharma Inc Latest Developments

11.2 AIT Austrian Institute of Technology GmbH

11.2.1 AIT Austrian Institute of Technology GmbH Company Information

11.2.2 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product Offered

11.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 AIT Austrian Institute of Technology GmbH Main Business Overview

11.2.5 AIT Austrian Institute of Technology GmbH Latest Developments

11.3 Courtagen Life Sciences Inc

11.3.1 Courtagen Life Sciences Inc Company Information

11.3.2 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product Offered

11.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Courtagen Life Sciences Inc Main Business Overview

11.3.5 Courtagen Life Sciences Inc Latest Developments

11.4 DiagnoCure Inc. (Inactive)

11.4.1 DiagnoCure Inc. (Inactive) Company Information

11.4.2 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product Offered

11.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 DiagnoCure Inc. (Inactive) Main Business Overview

11.4.5 DiagnoCure Inc. (Inactive) Latest Developments

11.5 BioMark Diagnostics Inc.

11.5.1 BioMark Diagnostics Inc. Company Information

11.5.2 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product Offered

11.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 BioMark Diagnostics Inc. Main Business Overview

11.5.5 BioMark Diagnostics Inc. Latest Developments

11.6 BioMarker Strategies LLC

11.6.1 BioMarker Strategies LLC Company Information

11.6.2 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product Offered

11.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 BioMarker Strategies LLC Main Business Overview

11.6.5 BioMarker Strategies LLC Latest Developments

11.7 Emory University

11.7.1 Emory University Company Information

11.7.2 Emory University Lung Cancer Diagnostic Tests Product Offered

11.7.3 Emory University Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Emory University Main Business Overview

11.7.5 Emory University Latest Developments

11.8 Epigenomics AG

11.8.1 Epigenomics AG Company Information

11.8.2 Epigenomics AG Lung Cancer Diagnostic Tests Product Offered

11.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Epigenomics AG Main Business Overview

11.8.5 Epigenomics AG Latest Developments

11.9 GlycoZym

11.9.1 GlycoZym Company Information

11.9.2 GlycoZym Lung Cancer Diagnostic Tests Product Offered

11.9.3 GlycoZym Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 GlycoZym Main Business Overview

11.9.5 GlycoZym Latest Developments

11.10 HalioDx SAS

11.10.1 HalioDx SAS Company Information

11.10.2 HalioDx SAS Lung Cancer Diagnostic Tests Product Offered

11.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 HalioDx SAS Main Business Overview

11.10.5 HalioDx SAS Latest Developments

11.11 Louisville Bioscience, Inc.

11.11.1 Louisville Bioscience, Inc. Company Information

11.11.2 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Product Offered

11.11.3 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Louisville Bioscience, Inc. Main Business Overview

11.11.5 Louisville Bioscience, Inc. Latest Developments

11.12 Mayo Clinic US

11.12.1 Mayo Clinic US Company Information

11.12.2 Mayo Clinic US Lung Cancer Diagnostic Tests Product Offered

11.12.3 Mayo Clinic US Lung Cancer Diagnostic Tests Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Mayo Clinic US Main Business Overview

11.12.5 Mayo Clinic US Latest Developments

12 Research Findings and Conclusion

Table 1. Lung Cancer Diagnostic Tests Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Immunoassays

Table 3. Major Players of Flow Cytometry

Table 4. Major Players of Rapid Tests

Table 5. Major Players of Molecular Assays

Table 6. Major Players of Tissue Arrays

Table 7. Major Players of Circulating Tumor Cells

Table 8. Major Players of Pharmacodiagnostics

Table 9. Major Players of Biomarkers

Table 10. Major Players of Other Diagnostics Methods

Table 11. Lung Cancer Diagnostic Tests Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 12. Global Lung Cancer Diagnostic Tests Market Size by Type (2017-2022) & ($ Millions)

Table 13. Global Lung Cancer Diagnostic Tests Market Size Market Share by Type (2017-2022)

Table 14. Lung Cancer Diagnostic Tests Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 15. Global Lung Cancer Diagnostic Tests Market Size by Application (2017-2022) & ($ Millions)

Table 16. Global Lung Cancer Diagnostic Tests Market Size Market Share by Application (2017-2022)

Table 17. Global Lung Cancer Diagnostic Tests Revenue by Players (2020-2022) & ($ Millions)

Table 18. Global Lung Cancer Diagnostic Tests Revenue Market Share by Player (2020-2022)

Table 19. Lung Cancer Diagnostic Tests Key Players Head office and Products Offered

Table 20. Lung Cancer Diagnostic Tests Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 21. New Products and Potential Entrants

Table 22. Mergers & Acquisitions, Expansion

Table 23. Global Lung Cancer Diagnostic Tests Market Size by Regions 2017-2022 & ($ Millions)

Table 24. Global Lung Cancer Diagnostic Tests Market Size Market Share by Regions (2017-2022)

Table 25. Americas Lung Cancer Diagnostic Tests Market Size by Country (2017-2022) & ($ Millions)

Table 26. Americas Lung Cancer Diagnostic Tests Market Size Market Share by Country (2017-2022)

Table 27. Americas Lung Cancer Diagnostic Tests Market Size by Type (2017-2022) & ($ Millions)

Table 28. Americas Lung Cancer Diagnostic Tests Market Size Market Share by Type (2017-2022)

Table 29. Americas Lung Cancer Diagnostic Tests Market Size by Application (2017-2022) & ($ Millions)

Table 30. Americas Lung Cancer Diagnostic Tests Market Size Market Share by Application (2017-2022)

Table 31. APAC Lung Cancer Diagnostic Tests Market Size by Region (2017-2022) & ($ Millions)

Table 32. APAC Lung Cancer Diagnostic Tests Market Size Market Share by Region (2017-2022)

Table 33. APAC Lung Cancer Diagnostic Tests Market Size by Type (2017-2022) & ($ Millions)

Table 34. APAC Lung Cancer Diagnostic Tests Market Size Market Share by Type (2017-2022)

Table 35. APAC Lung Cancer Diagnostic Tests Market Size by Application (2017-2022) & ($ Millions)

Table 36. APAC Lung Cancer Diagnostic Tests Market Size Market Share by Application (2017-2022)

Table 37. Europe Lung Cancer Diagnostic Tests Market Size by Country (2017-2022) & ($ Millions)

Table 38. Europe Lung Cancer Diagnostic Tests Market Size Market Share by Country (2017-2022)

Table 39. Europe Lung Cancer Diagnostic Tests Market Size by Type (2017-2022) & ($ Millions)

Table 40. Europe Lung Cancer Diagnostic Tests Market Size Market Share by Type (2017-2022)

Table 41. Europe Lung Cancer Diagnostic Tests Market Size by Application (2017-2022) & ($ Millions)

Table 42. Europe Lung Cancer Diagnostic Tests Market Size Market Share by Application (2017-2022)

Table 43. Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Region (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Lung Cancer Diagnostic Tests Market Size Market Share by Region (2017-2022)

Table 45. Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Type (2017-2022) & ($ Millions)

Table 46. Middle East & Africa Lung Cancer Diagnostic Tests Market Size Market Share by Type (2017-2022)

Table 47. Middle East & Africa Lung Cancer Diagnostic Tests Market Size by Application (2017-2022) & ($ Millions)

Table 48. Middle East & Africa Lung Cancer Diagnostic Tests Market Size Market Share by Application (2017-2022)

Table 49. Key Market Drivers & Growth Opportunities of Lung Cancer Diagnostic Tests

Table 50. Key Market Challenges & Risks of Lung Cancer Diagnostic Tests

Table 51. Key Industry Trends of Lung Cancer Diagnostic Tests

Table 52. Global Lung Cancer Diagnostic Tests Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 53. Global Lung Cancer Diagnostic Tests Market Size Market Share Forecast by Regions (2023-2028)

Table 54. Global Lung Cancer Diagnostic Tests Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 55. Global Lung Cancer Diagnostic Tests Market Size Market Share Forecast by Type (2023-2028)

Table 56. Global Lung Cancer Diagnostic Tests Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 57. Global Lung Cancer Diagnostic Tests Market Size Market Share Forecast by Application (2023-2028)

Table 58. Advpharma Inc Details, Company Type, Lung Cancer Diagnostic Tests Area Served and Its Competitors

Table 59. Advpharma Inc Lung Cancer Diagnostic Tests Product Offered

Table 60. Advpharma Inc Lung Cancer Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Advpharma Inc Main Business

Table 62. Advpharma Inc Latest Developments

Table 63. AIT Austrian Institute of Technology GmbH Details, Company Type, Lung Cancer Diagnostic Tests Area Served and Its Competitors

Table 64. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product Offered

Table 65. AIT Austrian Institute of Technology GmbH Main Business

Table 66. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. AIT Austrian Institute of Technology GmbH Latest Developments

Table 68. Courtagen Life Sciences Inc Details, Company Type, Lung Cancer Diagnostic Tests Area Served and Its Competitors

Table 69. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product Offered

Table 70. Courtagen Life Sciences Inc Main Business

Table 71. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Courtagen Life Sciences Inc Latest Developments

Table 73. DiagnoCure Inc. (Inactive) Details, Company Type, Lung Cancer Diagnostic Tests Area Served and Its Competitors

Table 74. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product Offered

Table 75. DiagnoCure Inc. (Inactive) Main Business

Table 76. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. DiagnoCure Inc. (Inactive) Latest Developments

Table 78. BioMark Diagnostics Inc. Details, Company Type, Lung Cancer Diagnostic Tests Area Served and Its Competitors

Table 79. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product Offered

Table 80. BioMark Diagnostics Inc. Main Business

Table 81. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. BioMark Diagnostics Inc. Latest Developments

Table 83. BioMarker Strategies LLC Details, Company Type, Lung Cancer Diagnostic Tests Area Served and Its Competitors

Table 84. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product Offered

Table 85. BioMarker Strategies LLC Main Business

Table 86. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. BioMarker Strategies LLC Latest Developments

Table 88. Emory University Details, Company Type, Lung Cancer Diagnostic Tests Area Served and Its Competitors

Table 89. Emory University Lung Cancer Diagnostic Tests Product Offered

Table 90. Emory University Main Business

Table 91. Emory University Lung Cancer Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Emory University Latest Developments

Table 93. Epigenomics AG Details, Company Type, Lung Cancer Diagnostic Tests Area Served and Its Competitors

Table 94. Epigenomics AG Lung Cancer Diagnostic Tests Product Offered

Table 95. Epigenomics AG Main Business

Table 96. Epigenomics AG Lung Cancer Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. Epigenomics AG Latest Developments

Table 98. GlycoZym Details, Company Type, Lung Cancer Diagnostic Tests Area Served and Its Competitors

Table 99. GlycoZym Lung Cancer Diagnostic Tests Product Offered

Table 100. GlycoZym Main Business

Table 101. GlycoZym Lung Cancer Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. GlycoZym Latest Developments

Table 103. HalioDx SAS Details, Company Type, Lung Cancer Diagnostic Tests Area Served and Its Competitors

Table 104. HalioDx SAS Lung Cancer Diagnostic Tests Product Offered

Table 105. HalioDx SAS Main Business

Table 106. HalioDx SAS Lung Cancer Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 107. HalioDx SAS Latest Developments

Table 108. Louisville Bioscience, Inc. Details, Company Type, Lung Cancer Diagnostic Tests Area Served and Its Competitors

Table 109. Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Product Offered

Table 110. Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 111. Louisville Bioscience, Inc. Main Business

Table 112. Louisville Bioscience, Inc. Latest Developments

Table 113. Mayo Clinic US Details, Company Type, Lung Cancer Diagnostic Tests Area Served and Its Competitors

Table 114. Mayo Clinic US Lung Cancer Diagnostic Tests Product Offered

Table 115. Mayo Clinic US Main Business

Table 116. Mayo Clinic US Lung Cancer Diagnostic Tests Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 117. Mayo Clinic US Latest Developments

List of Figures

Figure 1. Lung Cancer Diagnostic Tests Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Lung Cancer Diagnostic Tests Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Lung Cancer Diagnostic Tests Market Size Market Share by Type in 2021

Figure 7. Lung Cancer Diagnostic Tests in Precision Medicine

Figure 8. Global Lung Cancer Diagnostic Tests Market: Precision Medicine (2017-2022) & ($ Millions)

Figure 9. Lung Cancer Diagnostic Tests in Personalized Medicine

Figure 10. Global Lung Cancer Diagnostic Tests Market: Personalized Medicine (2017-2022) & ($ Millions)

Figure 11. Lung Cancer Diagnostic Tests in Cancer Monitoring

Figure 12. Global Lung Cancer Diagnostic Tests Market: Cancer Monitoring (2017-2022) & ($ Millions)

Figure 13. Global Lung Cancer Diagnostic Tests Market Size Market Share by Application in 2021

Figure 14. Global Lung Cancer Diagnostic Tests Revenue Market Share by Player in 2021

Figure 15. Global Lung Cancer Diagnostic Tests Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Lung Cancer Diagnostic Tests Market Size 2017-2022 ($ Millions)

Figure 17. APAC Lung Cancer Diagnostic Tests Market Size 2017-2022 ($ Millions)

Figure 18. Europe Lung Cancer Diagnostic Tests Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Lung Cancer Diagnostic Tests Market Size 2017-2022 ($ Millions)

Figure 20. Americas Lung Cancer Diagnostic Tests Value Market Share by Country in 2021

Figure 21. Americas Lung Cancer Diagnostic Tests Consumption Market Share by Type in 2021

Figure 22. Americas Lung Cancer Diagnostic Tests Market Size Market Share by Application in 2021

Figure 23. United States Lung Cancer Diagnostic Tests Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Lung Cancer Diagnostic Tests Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Lung Cancer Diagnostic Tests Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Lung Cancer Diagnostic Tests Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Lung Cancer Diagnostic Tests Market Size Market Share by Region in 2021

Figure 28. APAC Lung Cancer Diagnostic Tests Market Size Market Share by Application in 2021

Figure 29. China Lung Cancer Diagnostic Tests Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Lung Cancer Diagnostic Tests Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Lung Cancer Diagnostic Tests Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Lung Cancer Diagnostic Tests Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Lung Cancer Diagnostic Tests Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Lung Cancer Diagnostic Tests Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Lung Cancer Diagnostic Tests Market Size Market Share by Country in 2021

Figure 36. Europe Lung Cancer Diagnostic Tests Market Size Market Share by Type in 2021

Figure 37. Europe Lung Cancer Diagnostic Tests Market Size Market Share by Application in 2021

Figure 38. Germany Lung Cancer Diagnostic Tests Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Lung Cancer Diagnostic Tests Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Lung Cancer Diagnostic Tests Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Lung Cancer Diagnostic Tests Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Lung Cancer Diagnostic Tests Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Lung Cancer Diagnostic Tests Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Lung Cancer Diagnostic Tests Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Lung Cancer Diagnostic Tests Market Size Market Share by Application in 2021

Figure 46. Egypt Lung Cancer Diagnostic Tests Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Lung Cancer Diagnostic Tests Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Lung Cancer Diagnostic Tests Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Lung Cancer Diagnostic Tests Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Lung Cancer Diagnostic Tests Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 52. APAC Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 53. Europe Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 55. United States Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 56. Canada Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 59. China Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 60. Japan Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 61. Korea Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 63. India Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 64. Australia Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 65. Germany Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 66. France Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 67. UK Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 68. Italy Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 69. Russia Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 70. Spain Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 73. Israel Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Lung Cancer Diagnostic Tests Market Size 2023-2028 ($ Millions)